Chien‐Yi Hsu

Incident ocular outcomes with tirzepatide versus GLP-1 receptor agonists and conventional therapies in diabetes and obesity: a retrospective cohort study from a global federated health research network

Abstract Background To evaluate incident ophthalmic complications in adults initiating tirzepatide for type 2 diabetes mellitus (T2DM) or overweight/obesity without diabetes, compared with glucagon-like peptide-1 receptor agonists (GLP-1RAs) and conventional therapies. Methods We...